Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Bikang Pharmaceutical is a key subsidiary and manufacturing hub of the Bikang Pharmaceutical Group, a major Chinese healthcare enterprise. The company focuses on the development and production of a wide array of pharmaceutical products, including chemical generics, traditional Chinese medicines (TCM), and over-the-counter (OTC) medications. Its portfolio covers critical therapeutic areas such as cardiovascular health, respiratory diseases, and pediatrics, with well-known brands in the Chinese market. Hainan Bikang operates advanced production lines that comply with national GMP standards, supporting the group's large-scale supply chain. As part of the publicly traded Bikang Group, it plays a vital role in the parent company's integrated pharmaceutical industrial chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan BiKang Pharmaceutical.